Updated 2026-03-27 · NCT06602141See eligibility →
Sponsor
Clinical trials sponsored by AdventHealth Translational Research Institute
Active studies whose public registry record names AdventHealth Translational Research Institute as lead sponsor.
6active studies
1recruiting now
1countries represented
2largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Active, not recruitingNot applicable
Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)
Updated 2026-03-30 · NCT01911091See eligibility →
Active, not recruitingPhase 1
To Determine Tolerability to Glucagon Infusion in Obese Subjects
Updated 2026-03-30 · NCT02817659See eligibility →
Active, not recruitingPhase 1
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
Updated 2026-03-30 · NCT03139305See eligibility →
Active, not recruitingNot applicable
Epigenetic Regulation of Human Adipose Tissue Distribution
Updated 2026-03-27 · NCT02728635See eligibility →
Active, not recruitingNot applicable
Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL)
Updated 2025-08-03 · NCT01745471See eligibility →
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.